Inactive

1) Additional (final) Q&As (#4) posted Mar 4, 2021: See Additional Q&As (#4) to the solicitation/RFQ posted on Feb 23, 2021. Response time for receipt of quotes is not changed. 2) Additional Q&As (#3)... 1) Additional (final) Q&As (#4) posted Mar 4, 2021: See Additional Q&As (#4) to the solicitation/RFQ posted on Feb 23, 2021. Response time for receipt of quotes is not changed. 2) Additional Q&As (#3) posted Mar 2, 2021: See Additional Q&As (#3) to the solicitation/RFQ posted on Feb 23, 2021. Response time for receipt of quotes is not changed. 3) Additional Q&As posted Mar 2, 2021: See Additional Q&As to the solicitation/RFQ posted on Feb 23, 2021. Response time for receipt of quotes is not changed. 4) Q&As posted Mar 1, 2021: See attached Questions submitted in response to the original posting of the solicitation/RFQ on Feb 23, 2021 and corresponding answers from the Government. 5) Amendment A00001 posting on Feb 25, 2021: See attached Amended Request for Quote (RFQ), Amended as of February 25, 2021. This Amended document has some changes which are highlighted by a thick bold line in the left margin of the document. Please ensure you are using the version with "Amendment A00001" in the Document Header. All interested parties submitting quotes in response to this RFQ shall indicate they are responding to the Amended solicitation when submitting quotes. 6) Original Posting on Feb 23, 2021: Please see attached Request for Quote (RFQ) for COVID-19 testing for FDA employees and contractors.